Chronic kidney disease (CKD) is characterized by gut
dysbiosis with a decrease in
short-chain fatty acid (SCFA)-producing bacteria. Levels of
protein-bound
uremic toxins (PBUTs) and post-translational modifications (PTMs) of
albumin increase with CKD, both risk factors for cardiovascular morbidity and mortality. The relationship between fecal metabolites and plasma concentrations of PBUTs in different stages of CKD (n = 103) was explored. Estimated GFR tends to correlate with fecal
butyric acid (BA) concentrations (rs = 0.212; p = 0.032), which, in its turn, correlates with the abundance of SCFA-producing bacteria. Specific SCFAs correlate with concentrations of PBUT precursors in feces. Fecal levels of
p-cresol correlate with its derived plasma UTs (p-cresyl
sulfate: rs = 0.342, p < 0.001; p-cresyl
glucuronide: rs = 0.268, p = 0.006), whereas an association was found between fecal and plasma levels of
indole acetic acid (rs = 0.306; p = 0.002). Finally, the
albumin symmetry factor correlates positively with eGFR (rs = 0.274; p = 0.005). The decreased abundance of SCFA-producing gut bacteria in parallel with the fecal concentration of BA and
indole could compromise the intestinal barrier function in CKD. It is currently not known if this contributes to increased plasma levels of PBUTs, potentially playing a role in the PTMs of
albumin. Further evaluation of SCFA-producing bacteria and SCFAs as potential targets to restore both gut
dysbiosis and
uremia is needed.